Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-21-001359

Options or other derivatives

  • Chief Legal Officer acquired 249,998 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Keane Raymond T · Chief Legal Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-01-07 Grant or award : show line 1 in the form Stock Option (Right to Buy) +249,998 249,998 D
Loading xslF345X03/doc4.xml…